Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Galderma R&D
This study is to assess the PK/PD relationship of nemolizumab in adult participants with CPUO. The study will consist of a 2 to 4-week screening period, a 16-week treatment period, and an 8-week follow up period (12 weeks after last study drug injection). Participants will be randomized 4:1 to nemolizumab or placebo. Dosing will be adjusted according to participants body weight ( less than \[\<\] 90 kilograms \[kg\] versus \>= 90 kg). Participation in the study will last up to 28 weeks.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
